When lung cancer spreads to the membranes surrounding the brain and spinal cord, it is called leptomeningeal metastasis. This condition is difficult to treat because standard drugs often have trouble reaching these areas in high enough amounts. To solve this, doctors can use intrathecal chemotherapy, which delivers medicine directly into the spinal fluid through a lumbar puncture or a small reservoir.
A review of 544 patients showed that this targeted delivery method helps control the disease. About 62.5% to 94.9% of patients saw their disease stay stable or shrink. While survival times varied, some patients lived between 3.66 and 17 months after starting treatment. These results suggest that delivering drugs directly where they are needed can provide significant benefits for patients facing this specific type of spread.
Safety is a key part of the conversation. More than 10% of patients experienced side effects like low blood counts, stomach issues, or neurological symptoms. However, doctors generally found these risks to be manageable. Because results vary across different trials and patient groups, it is important for patients to discuss how this specific approach might fit their unique situation with their medical team.
